1. Clin Exp Dermatol. 2023 Nov 13:llad387. doi: 10.1093/ced/llad387. Online ahead
 of print.

Cutaneous Adverse-Effects Induced by Tebentafusp in Patients with Metastatic 
Uveal Melanoma: A Case Series and Treatment Insights.

Rodriguez I(1), Norman T(1), Guenther J(1), Smart K(1), Kwong A(2), Berry J(3), 
In GK(2)(4), Worswick S(2).

Author information:
(1)Keck School of Medicine, University of Southern California, Los Angeles, CA, 
USA.
(2)Department of Dermatology, Keck School of Medicine, University of Southern 
California, Los Angeles, CA, USA.
(3)Department of Ophthalmology, Keck School of Medicine, University of Southern 
California, Los Angeles, CA, USA.
(4)Division of Oncology, Norris Comprehensive Cancer Center, Keck School of 
Medicine, University of Southern California, Los Angeles, CA, USA.

DOI: 10.1093/ced/llad387
PMID: 37956104
